Medical Xpress

Ubrogepant beneficial for treating migraine during the prodrome

Ubrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet. David W. Dodick, M.D., from the Mayo Clinic in ...
MedPage Today

Ubrogepant in Migraine Prodrome Helps Patients Return to Normal Function Sooner

Treatment with oral ubrogepant (Ubrelvy) during the migraine prodrome led to more patients being able to function normally, a prespecified secondary endpoint analysis of the phase III PRODROME trial ...
Medscape

CGRP in Migraine Prodrome Can Stop Headache, Reduce Severity

BARCELONA — For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache. In ...
WDAF-TV

Results Published in The Lancet Show UBRELVY® (ubrogepant) Reduces the Headache Phase of a Migraine Attack When Dosed During the Prodrome of Migraine

- More patients treated with UBRELVY ® 100 mg during the prodrome avoided the development of moderate or severe headache within 24 hours post-dose vs. placebo in those who could identify prodrome ...
Medical News Today

Can taking a migraine drug just as an attack sets in stop it in its tracks?

Share on Pinterest Taken at onset, ubrogepant may stop migraine attacks in their tracks. Image credit: Guido Mieth/Getty Images. Migraine attacks are painful events that can cause many unpleasant ...